Efficacy News and Research

RSS
Celgene announces interim results of REVLIMID study on CLL

Celgene announces interim results of REVLIMID study on CLL

Research assesses safety and efficacy of pre-operative transfusions, hydroxyurea therapy for SCD

Research assesses safety and efficacy of pre-operative transfusions, hydroxyurea therapy for SCD

Research examines novel treatment techniques for hemophilia B, VTE

Research examines novel treatment techniques for hemophilia B, VTE

Onyx announces data from three carfilzomib studies on RRMM

Onyx announces data from three carfilzomib studies on RRMM

New research on diagnosis and treatment of leukemia to be presented at 53rd ASH meeting

New research on diagnosis and treatment of leukemia to be presented at 53rd ASH meeting

New cancer research findings presented at 53rd ASH annual meeting

New cancer research findings presented at 53rd ASH annual meeting

Memgen to present ISF35 clinical trial data on CLL at 53rd ASH meeting

Memgen to present ISF35 clinical trial data on CLL at 53rd ASH meeting

Abbott commences Absorb-XIENCE PRIME comparative clinical trial

Abbott commences Absorb-XIENCE PRIME comparative clinical trial

Positive results from Puma's neratinib Phase II trials presented at CTRC-AACR San Antonio Breast Cancer Symposium

Positive results from Puma's neratinib Phase II trials presented at CTRC-AACR San Antonio Breast Cancer Symposium

VIVUS announces results of Qnexa clinical study on cardiometabolic disease

VIVUS announces results of Qnexa clinical study on cardiometabolic disease

FDA committee votes against CardioMEMS' Champion Heart Failure Monitoring System

FDA committee votes against CardioMEMS' Champion Heart Failure Monitoring System

Galectin Therapeutics to initiate GM-CT-01 Phase 1/2 combination study in advanced MM

Galectin Therapeutics to initiate GM-CT-01 Phase 1/2 combination study in advanced MM

ChemoCentryx commences CCX140 Phase II trial in diabetic nephropathy

ChemoCentryx commences CCX140 Phase II trial in diabetic nephropathy

FDA advisory panel OKs anemia drug peginesatide

FDA advisory panel OKs anemia drug peginesatide

CRD to conduct review of safety and effectiveness of BMP-2

CRD to conduct review of safety and effectiveness of BMP-2

Olympus releases Acecide-C High-Level Disinfectant and Sterilant

Olympus releases Acecide-C High-Level Disinfectant and Sterilant

Updated data from Novartis Afinitor plus everolimus Phase III study on advanced breast cancer

Updated data from Novartis Afinitor plus everolimus Phase III study on advanced breast cancer

Positive results from Pearl Therapeutics' PT001 Phase 2b trial on COPD

Positive results from Pearl Therapeutics' PT001 Phase 2b trial on COPD

Milk powder outperforms lower-dose therapy for treatment of food allergies

Milk powder outperforms lower-dose therapy for treatment of food allergies

Hormone-blocking therapy for prostate cancer does not raise risk of heart attacks

Hormone-blocking therapy for prostate cancer does not raise risk of heart attacks

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.